secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001193125-24-182860
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics receives Nasdaq minimum bid price deficiency notice; has until Jan 15, 2025 to cure
--------------------------------------------------------------------------------

- Nasdaq notified Lyra on July 19, 2024 that its common stock (LYRA) closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until January 15, 2025, to regain compliance by closing at or above $1.00 for 10 consecutive days.
- If not cured, Lyra may transfer to Nasdaq Capital Market and get an additional 180-day compliance period.
- Failure to regain compliance could result in delisting; the company intends to monitor and consider available options.
- Stock continues trading on Nasdaq Global Market under symbol LYRA during the cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524182860/0001193125-24-182860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312524182860/d871197d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-182860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer